Search research articles
Contact Us
Filters
Showing results (51-60 of 96) with videos related to
Page
of 10
Sort By:
Scientific Reports
|
September 29, 2018
A one-step procedure to probe the viscoelastic properties of cells by Atomic Force Microscopy
Ya Hua Chim, Louise M Mason, Nicola Rath, et al.
Disease Models & Mechanisms
|
April 15, 2024
Caspase-resistant ROCK1 expression prolongs survival of Eµ-Myc B cell lymphoma mice
Katerina Mardilovich, Gregory Naylor, Linda Julian, et al.
Journal of Biomolecular Screening
|
December 14, 2011
Development of a high-throughput screening method for LIM kinase 1 using a luciferase-based assay of ATP consumption
Mokdad Mezna, Ai Ching Wong, Margaret Ainger, et al.
The American Journal of Pathology
|
July 9, 2013
Mechanotransduction pathways promoting tumor progression are activated in invasive human squamous cell carcinoma
S Jan Ibbetson, Natasha T Pyne, Anthony N Pollard, et al.
Genes, Brain, and Behavior
|
September 30, 2024
Mical1 deletion in tyrosinase expressing cells affects mouse running gaits
Katarina Micovic, Alicia Canuel, Aasiya Remtulla, et al.
Molecular and Cellular Biology
|
October 14, 2009
MST kinases monitor actin cytoskeletal integrity and signal via c-Jun N-terminal kinase stress-activated kinase to regulate p21Waf1/Cip1 stability
Ruth M Densham, Eric O'Neill, June Munro, et al.
Cancer Research
|
August 20, 2009
Sprouty2 association with B-Raf is regulated by phosphorylation and kinase conformation
Suzanne C Brady, Mathew L Coleman, June Munro, et al.
Molecular Cancer Therapeutics
|
October 26, 2014
Elevated LIM kinase 1 in nonmetastatic prostate cancer reflects its role in facilitating androgen receptor nuclear translocation
Katerina Mardilovich, Mads Gabrielsen, Lynn McGarry, et al.
Cell Reports
|
October 5, 2022
MICAL1 activation by PAK1 mediates actin filament disassembly
David J McGarry, Giovanni Castino, Sergio Lilla, et al.
Cancer Research
|
August 18, 2004
SPRY2 is an inhibitor of the ras/extracellular signal-regulated kinase pathway in melanocytes and melanoma cells with wild-type BRAF but not with the V599E mutant
Dimitra Tsavachidou, Mathew L Coleman, Galene Athanasiadis, et al.
Page
of 10
Search research articles
Search
Showing results (51-60 of 96) with videos related to
Sort By:
Page
of 10
Scientific Reports
|
September 29, 2018
A one-step procedure to probe the viscoelastic properties of cells by Atomic Force Microscopy
Ya Hua Chim, Louise M Mason, Nicola Rath, et al.
Disease Models & Mechanisms
|
April 15, 2024
Caspase-resistant ROCK1 expression prolongs survival of Eµ-Myc B cell lymphoma mice
Katerina Mardilovich, Gregory Naylor, Linda Julian, et al.
Journal of Biomolecular Screening
|
December 14, 2011
Development of a high-throughput screening method for LIM kinase 1 using a luciferase-based assay of ATP consumption
Mokdad Mezna, Ai Ching Wong, Margaret Ainger, et al.
The American Journal of Pathology
|
July 9, 2013
Mechanotransduction pathways promoting tumor progression are activated in invasive human squamous cell carcinoma
S Jan Ibbetson, Natasha T Pyne, Anthony N Pollard, et al.
Genes, Brain, and Behavior
|
September 30, 2024
Mical1 deletion in tyrosinase expressing cells affects mouse running gaits
Katarina Micovic, Alicia Canuel, Aasiya Remtulla, et al.
Molecular and Cellular Biology
|
October 14, 2009
MST kinases monitor actin cytoskeletal integrity and signal via c-Jun N-terminal kinase stress-activated kinase to regulate p21Waf1/Cip1 stability
Ruth M Densham, Eric O'Neill, June Munro, et al.
Cancer Research
|
August 20, 2009
Sprouty2 association with B-Raf is regulated by phosphorylation and kinase conformation
Suzanne C Brady, Mathew L Coleman, June Munro, et al.
Molecular Cancer Therapeutics
|
October 26, 2014
Elevated LIM kinase 1 in nonmetastatic prostate cancer reflects its role in facilitating androgen receptor nuclear translocation
Katerina Mardilovich, Mads Gabrielsen, Lynn McGarry, et al.
Cell Reports
|
October 5, 2022
MICAL1 activation by PAK1 mediates actin filament disassembly
David J McGarry, Giovanni Castino, Sergio Lilla, et al.
Cancer Research
|
August 18, 2004
SPRY2 is an inhibitor of the ras/extracellular signal-regulated kinase pathway in melanocytes and melanoma cells with wild-type BRAF but not with the V599E mutant
Dimitra Tsavachidou, Mathew L Coleman, Galene Athanasiadis, et al.
Page
of 10